VKTX
Viking Therapeutics Inc
Price:  
30.40 
USD
Volume:  
5,621,034.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VKTX Intrinsic Value

-118.78 %
Upside

What is the intrinsic value of VKTX?

As of 2025-07-10, the Intrinsic Value of Viking Therapeutics Inc (VKTX) is -5.71 USD. This VKTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 30.40 USD, the upside of Viking Therapeutics Inc is -118.78%.

Is VKTX undervalued or overvalued?

Based on its market price of 30.40 USD and our intrinsic valuation, Viking Therapeutics Inc (VKTX) is overvalued by 118.78%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

30.40 USD
Stock Price
-5.71 USD
Intrinsic Value
Intrinsic Value Details

VKTX Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -5.71 - -5.71 -5.71 -118.78%
P/E (20.03) - (27.61) (24.69) -181.2%
DDM - Stable (7.57) - (27.21) (17.39) -157.2%
DDM - Multi (0.19) - (0.53) (0.28) -100.9%

VKTX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3,414.22
Beta 1.31
Outstanding shares (mil) 112.31
Enterprise Value (mil) 3,376.28
Market risk premium 4.60%
Cost of Equity 11.17%
Cost of Debt 5.00%
WACC 7.42%